Arterial stiffness is measured by pulse wave velocity (PWV), which increases throughout everyone's lifespan, typically from about 5 in your 30s to around 10 in your 60s.
Yet clinical trials have confirmed that MenaQ7® K2 supplementation stopped and even reversed arterial stiffening, revealing more flexible arteries for better blood flow as evidenced by reduced PWV measurements compared to placebo groups.
No other compound (or K2, for that matter) has been shown to impact arterial stiffening, making MenaQ7® K2 the key to breaking the vascular calcification curve.
